DunedinPACE, a DNA methylation biomarker of the pace of aging
Human, observationaleLife
Summary
The authors built DunedinPACE, a single-timepoint blood DNA-methylation biomarker of the pace of biological ageing. They distilled a two-decade pace-of-ageing measure from the Dunedin Study birth cohort, tracking decline across 19 organ-system indicators, into an elastic-net model trained on methylation probes with high test-retest reliability. The measure was then tested in five further datasets, where it showed high test-retest reliability and was associated with morbidity, disability and mortality, with effect sizes similar to GrimAge and added prediction beyond it.
Key points
- DunedinPACE is a blood DNA-methylation biomarker of pace of ageing, derived from a 19-indicator organ-integrity decline measure in the Dunedin Study.
- It was built with elastic-net regression on probes restricted to high test-retest reliability.
- Reported high test-retest reliability and associations with morbidity, disability and mortality.
- Effect sizes were similar to GrimAge, and it added incremental prediction beyond GrimAge for incident outcomes.